Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/3f/64/ea/3f64ead3-ffcf-1c6e-f7dd-7431bab6e944/mza_7099564893497254319.jpg/600x600bb.jpg
SUFU podcast
SUFU podcast
91 episodes
3 months ago
https://jamanetwork.com/journals/jamasurgery/fullarticle/2805403 O’Shea M, Siddiqui NY, Truong T, Erkanli A, Barber MD. Standard Restrictions vs Expedited Activity After Pelvic Organ Prolapse Surgery: A Randomized Clinical Trial. JAMA Surg. 2023;158(8):797–805. doi:10.1001/jamasurg.2023.1649
Show more...
Science
RSS
All content for SUFU podcast is the property of SUFU podcast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
https://jamanetwork.com/journals/jamasurgery/fullarticle/2805403 O’Shea M, Siddiqui NY, Truong T, Erkanli A, Barber MD. Standard Restrictions vs Expedited Activity After Pelvic Organ Prolapse Surgery: A Randomized Clinical Trial. JAMA Surg. 2023;158(8):797–805. doi:10.1001/jamasurg.2023.1649
Show more...
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/3f/64/ea/3f64ead3-ffcf-1c6e-f7dd-7431bab6e944/mza_7099564893497254319.jpg/600x600bb.jpg
SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder
SUFU podcast
34 minutes
1 year ago
SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder
Moderator: J. Quentin Clemens, MD, FACS Risk Profile of Anticholinergic Agents vs Beta-3 Agonists Panelist: Anne M. Suskind, MD, MS, FACS, FPMRS Efficacy of Anticholinergic Agents vs Beta-3 Agonists Panelist: Blayne Welk, MD What About Neurogenic Bladder? Panelist: Christopher S. Elliott, MD, PhD
SUFU podcast
https://jamanetwork.com/journals/jamasurgery/fullarticle/2805403 O’Shea M, Siddiqui NY, Truong T, Erkanli A, Barber MD. Standard Restrictions vs Expedited Activity After Pelvic Organ Prolapse Surgery: A Randomized Clinical Trial. JAMA Surg. 2023;158(8):797–805. doi:10.1001/jamasurg.2023.1649